Global Surgical Glue Market Poised for Significant Growth

The Global Surgical Glue Market is experiencing substantial expansion, driven by advancements in medical procedures and a growing preference for minimally invasive surgeries. Valued at approximately USD 6.84 billion in 2023, the market is projected to reach nearly USD 13.16 billion by 2030, exhibiting a Compound Annual Growth Rate (CAGR) of 9.8% during the forecast period.

Competitive Landscape

The surgical glue industry is characterized by a blend of prominent international and regional players. Leading companies such as Baxter International Inc., B. Braun Melsungen AG, CryoLife Inc., Integra LifeSciences Corporation, and Advanced Medical Solutions Group plc are at the forefront, continually innovating to meet the evolving demands of healthcare professionals. These companies are investing heavily in research and development, marketing, and expanding their distribution networks to maintain a competitive edge.

For a thorough understanding of this study, refer to the following webpage:

https://www.maximizemarketresearch.com/request-sample/28962/

Regional Demand Highlights

North America holds a dominant position in the surgical glue market, accounting for a significant share of global revenue. This dominance is attributed to the region's advanced healthcare infrastructure and the presence of major market players. The United States, in particular, contributes substantially to this leadership.